IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Shasun completes US and Mexican regulatory inspections of Cuddalore API plant

11:08 AM MDT | July 8, 2014 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India) said today that it has successfully completed both US FDA and Mexican Cofepris regulatory inspections at its active pharma ingredients facility at Cuddalore, Tamil Nadu State, India. The FDA audit was held in the second week of June and the Cofepris audit by APIF during the last week of June. The FDA inspectors conclude that the facility, systems, and practices comply with FDA requirements, and, when done the inspection, APIF concluded that Shasun’s compliance with cGMP are fully met and that...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa